Previous studies report that TIGIT+ Tregs selectively suppress Th1 and Th17 responses (52) and TIGIT signaling counteracts IFN-γ production in Th1 Treg cells which are dysregulated in multiple sclerosis (53). This evidence concerns the gene IFNG and multiple sclerosis.